GlassScriptPhysician profile
Ryan Edward Rebowe
NPI 1508203456
$24,322.08
in general payments reported to CMS, 2019-2025
32 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,359 · 2020: $244 · 2021: $503 · 2022: $383 · 2023: $1,669 · 2024: $647 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Consulting Fee: $2,825 · Travel and Lodging: $2,209 · Food and Beverage: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Consulting Fee | $2,825.00 |
| Travel and Lodging | $2,208.62 |
| Food and Beverage | $1,799.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bimini Technologies LLC | $19,073.50 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,146.98 | 2019-2023 | |
| Mentor Worldwide LLC | $1,129.00 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Merz North America, INC. | $376.79 | 2019-2025 | Xeomin |
| Allergan, INC. | $364.64 | 2019-2022 | |
| Sientra, INC. | $278.52 | 2019-2022 | |
| Galderma Laboratories, L.P. | $244.39 | 2019-2025 | Dysport |
| Tela Bio, INC. | $222.70 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Abbvie INC. | $212.89 | 2023-2025 | |
| Kci USA, INC. | $168.95 | 2019-2022 | |
| Integra Lifesciences Corporation | $148.94 | 2023-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Tei Biosciences INC | $123.64 | 2019 | |
| Polarityte, INC. | $114.73 | 2019 | |
| Stryker Corporation | $104.96 | 2019 | |
| Polynovo North America LLC | $79.60 | 2024 | Novosorb Btm |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $68.28 | 2020-2023 | Na |
| Acell, INC. | $67.33 | 2019 | |
| Kls-Martin L.P. | $49.54 | 2024 | |
| Kerecis Limited | $47.43 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Convatec INC. | $41.19 | 2024-2025 | |
| Smith+Nephew, INC. | $36.69 | 2022-2024 | Collagenase Santyl |
| Organogenesis INC. | $35.62 | 2025 | Affinity, Cygnus Dual |
| Motiva USA, LLC | $35.23 | 2025 | |
| Davol INC. | $24.35 | 2024 | Arista Ah Flexitip |
| Vioptix INC | $23.61 | 2024 | T. Ox Tissue Oximeter |
| Bioventus LLC | $19.91 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.77 | 2023 | Exparel |
| Kowa Pharmaceuticals America, INC. | $15.81 | 2023 | Seglentis |
| Solventum Corporation | $15.77 | 2024 | Activ.A.C., V.A.C. Veraflo |
| Acera Surgical, INC. | $13.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $11.71 | 2022 | |
| Heraeus Medical, LLC. | $9.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Rebowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.